Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-488-0 | CAS number: 141-53-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Specific investigations: other studies
Administrative data
Link to relevant study record(s)
- Endpoint:
- specific investigations: other studies
- Type of information:
- not specified
- Adequacy of study:
- other information
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: Abstract
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Examination of cell viability, cellular formate concentration, cellular ATP levels using a photoreceptor cell line (661W)
- Conclusions:
- CL-Freetext:
The authors concluded that cytotoxicity was associated with
the undissociated formic acid, rather than with formate. - Endpoint:
- specific investigations: other studies
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Induction of optical nerve toxicity in rodents following treatment with nitrous oxide, N2O
- GLP compliance:
- not specified
- Type of method:
- in vivo
- Endpoint addressed:
- neurotoxicity
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Route of administration:
- other: i.p. injection
- Vehicle:
- physiological saline
- Remarks:
- Doses / Concentrations:
4 g methanol/ kg bw
Basis:
actual ingested - Control animals:
- yes, concurrent no treatment
- Details on study design:
- Folate levels, formate oxidation rates, and optical nerve function were measured in rats after receiving methanol. Rats were either non-pretreteated or had been pre-treated with nitrous oxide, N2O.
- Examinations:
- Hepatic folate levels, formate oxidation rates, and optical nerve function (electroretinogram (ERG) and flash-prooked cortical potential (FEP)).
- Conclusions:
- Nitrous oxide inhibits methionine synthetase in rats. This is associated with 50% reduced tetrahydrofolate levels and formate oxidation rate compared to untreated rats. Under these conditions methanol treatment results in acidosis, and morphological anf functional lesions of teh optical nerve and the retina, i.e. the same lesions that are seen in humans. Thus, an animal model for the methanol-induced retinal and optical nerve toxicity was established.
Ingestion of formate salts by humans could lead to the same adverse effects.
Intoxicated rats showed tetrahydrofolate levels, formate oxidation rates, blood pH and blood formate levels that were comparable to those observed in intoxicated monkeys and humans.
Functional and morphological changes in the retina were more pronounced than in the optical nerve after methanol intoxication with formate blood levels ranging between 8-15 mM over a time period of 30-40 hours. Comparable formate levels were seen in intoxicated monkeys and humans. - Endpoint:
- specific investigations: other studies
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Examination of blood formate levels and ocular morphology following methanol administartion and intravenous formate infusion into monkeys.
- GLP compliance:
- no
- Type of method:
- in vivo
- Endpoint addressed:
- neurotoxicity
- Species:
- monkey
- Strain:
- other: Macaca mulatta
- Sex:
- male
- Route of administration:
- other: i.v. infusion
- Vehicle:
- other: buffered aqueous solution
- Details on exposure:
- Four male rhesus monkeys (Macaca mulatta) received buffered Na-formate [(sodium formate: formic acid, 10:1 (0.5 M)] i.v. after a loading of 1.25 mmol/kg bw (57.5 mg/kg) sodium formate, with a mean infusion rate of 3.1 mEq/kg/h [142.6 mg/kg bw/h)].
- Duration of treatment / exposure:
- The animals were continuously infused for the whole study duration.
- Frequency of treatment:
- singly
- Remarks:
- Doses / Concentrations:
143 mg/kg bw/hour
Basis:
other: i.v. infusion - No. of animals per sex per dose:
- 4
- Conclusions:
- Fomate blood levels in the range of 450 mg/L and above (≥ 10 mM) may cause irreversible ocular damage in monkeys if persisting for several hours. This result (≥ 10 mM) can be extrapolated to humans.
- Executive summary:
Formate blood levels in the range of 450 mg/L and above (≥ 10 mM) may cause irreversible ocular damage in monkeys if persisting for several hours. This result can be extrapolated to humans.
Elevated blood formate levels were seen in monkeys receiving sodium form formate via i.v. infusion over several hours at a rate of 143 mg/kg bw/hour. The maximal levels ranged between 550 mg/L after 25 hours and 1560 mg/L after 40 hours. Moderate optical disk edema was seen in the animal with 550 mg/L, and severe effects were seen at 1000 mg/L and above.
These results with formate were completely consistent with those findings after methanol-intoxication. Formic acid and not formaldehyde (McMartin et al., 1979) has to be considered the causative agent for ocular damage within the methanol-intoxication syndrome, irrespective of acidosis. The mechanism of formate toxicity may be seen in the inhibition of oxidative phosphorylation by formate based on the on findings that this substance is an efficient inhibitor of cytochrome oxidase.
It should be noted that in an earlier publication (Martin-Amat et al. (1977); cited in the OECD SIDS) ocular effects were reported to occur in monkeys also at slightly lower blood formate levels (350 -550 mg/L, i.e.8 -12 mM). It was therefore concluded that clear signs of ocular damage may occur in monkeys at formate blood levels of approx. 450 mg/L an higher, i.e. ≥ 10 mM and above (OECD, 2004)
- Endpoint:
- specific investigations: other studies
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- abstract
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Examination of photoreceptor cell toxicity of formic acid and formate in vitro.
- GLP compliance:
- not specified
- Type of method:
- in vitro
- Endpoint addressed:
- neurotoxicity
- Specific details on test material used for the study:
- Formic acid (30 mM, pH 6.9)
or
Sodium formate (30 mM, pH 7.4) - Details on exposure:
- A photoreceptor cell line (661W cells) was exposed to either sodium formate (30 mM, pH 7.4) or formic acid (30 mM, pH 6.9).
- Analytical verification of doses or concentrations:
- not specified
- Examinations:
- Cellular formate concentrations, cellular ATP concentrations and cell viability were assessed at 2 h and 24 h after start of treatment.
- Conclusions:
- According to the authors these data provide evidence for pH dependent differences in the cytotoxic actions of formate. They are consistent with studies showing that the undissociated formic acid is the active inhibitor of mitochondrial cytochome oxidase and that formic acid is only permeable through the inner mitochondrial membrane in its undissociated form.
- Endpoint:
- specific investigations: other studies
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- abstract
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Examination of photoreceptor cell toxicity of formic acid and formate in vitro.
- GLP compliance:
- not specified
- Type of method:
- in vitro
- Endpoint addressed:
- neurotoxicity
- Specific details on test material used for the study:
- Formic acid (30 mM, pH 6.9)
or
Sodium formate (30 mM, pH 7.4) - Details on exposure:
- A photoreceptor cell line (661W cells) was exposed to either sodium formate (30 mM, pH 7.4) or formic acid (30 mM, pH 6.9).
- Analytical verification of doses or concentrations:
- not specified
- Examinations:
- Cellular formate concentrations, cellular ATP concentrations and cell viability were assessed at 2 h and 24 h after start of treatment.
- Conclusions:
- According to the authors these data provide evidence for pH dependent differences in the cytotoxic actions of formate. They are consistent with studies showing that the undissociated formic acid is the active inhibitor of mitochondrial cytochome oxidase and that formic acid is only permeable through the inner mitochondrial membrane in its undissociated form.
- Endpoint:
- specific investigations: other studies
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- secondary literature
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- No test guideline available. Interaction with mitochondrial electron chain was examined. Endpoint adressed: cellular energy supply.
- Type of method:
- in vitro
- Details on results:
- Formate is a moderate inhibitor of cytochrome c oxidase in vitro, the Ki is approx. 6 mM.
- Conclusions:
- Formate is a moderate inhibitor of cytochrome c oxidase. The Ki is approx. 6 mM.
- Endpoint:
- specific investigations: other studies
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- abstract
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- No test guideline available. Interaction with mitochondrial electron chain was examined. Endpoint adressed: cellular energy supply.
- GLP compliance:
- no
- Type of method:
- in vitro
- Endpoint addressed:
- not applicable
- Details on results:
- Formate inhibits cytochromecoxidase activity both in intact mitochondria and submitochondrial particles, and in isolated cytochromeaa3. The inhibition increases with decreasing pH, indicating that HCOOH may be the inhibitory species.
The Ki for formate inhibition of respiration is a function of the reduction state of the system, varying from 30 mM (100% reduction) to 1 mM (100% oxidation) at pH 7.4, 30 °C. - Conclusions:
- Formate is a moderate inhibitor of cytochrome c oxidase. The Ki is between 1 and 30 mM.
- Endpoint:
- specific investigations: other studies
- Type of information:
- not specified
- Adequacy of study:
- other information
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Metabolism of model intestinal epithelial cells and protection against Salmonella enteritidis in cell culture.
- Specific details on test material used for the study:
- Formate, proprionate, and butyrate.
- Conclusions:
- The authors concluded that formate is a potent growth
promoter and an inhibitor of differentiation in
enterocyte-like Caco-2 cells.
Propionate and butyrate showed different effects. - Endpoint:
- specific investigations: other studies
- Type of information:
- not specified
- Adequacy of study:
- other information
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Examination of the effects of formate in the isolated, microperfused mouse kidney proximal tubule.
- Specific details on test material used for the study:
- Sodium formate was obtained from Sigma
- Conclusions:
- The authors concluded that formate activates the apical
Na+/H+ exchanger NHE3 in the kidney proximal tubule. It
remains unknown whether other isoforms are also stimulated.
It was further concluded that the reabsorption of chloride in the proximal tubule is indirect and secondary, due to the
increased availability of substrate resulting from the activity of the Na+/H+ exchanger.
Referenceopen allclose all
RS-Freetext:
The intracellular formate concentration was more
significantly increased following treatment at pH 6.9
compared to the treatment at pH 7.4. Intracellular ATP was
not changed at pH 7.4, but at pH 6.9. Similarly, viability
was significantly decreased after 2 h at pH 6.9, but not at
pH 7.4.
===========================================================
Treatment
------------------------------------------------
Time 30 mM NaHCOO, pH 7.4 | 30 mM HCOOH, pH 6.9
-----------------------------------------------------------
Formate ATP | Formate ATP
(h) (µmol/mg protein) (%) | (µmol/mg protein) (%)
-----------------------------------------------------------
0 3 +/- 0.5 100 | 3 +/- 0.5 100
2 38 +/- 4 100 | 38 +/- 4 70
24 17 +/- 2 100 | 50 +/- 5 50
===========================================================
1. Hepatic folate concentrations and formate metabolism
Nitrous
oxide inhibits methionine synthetase in pretreated rats. Consequently,
the hepatic tetrahydrofolate (THF) level and the rate of formate
oxidation are both reduced to 50% compared to untreated rats. The
reduced levels are comparable to those observed in monkeys and humans.
Species |
Total hepatic folate (nmole/g) |
Hepatic tetrahydro-folate (nmole/g) |
Rate of formate oxidation (mg/kg/hr) |
Rat, untreated |
26.9±3.3 |
14.2 ± 0.9 |
69 ± 1.6 |
Rat, N2O-treated |
28.5 ± 1.2 |
8.5 ± 0.8 |
34 ± 1.0 |
Cynomolgus monkey |
25.5 ± 0.5 |
8.1 ± 0.2 |
34 ± 2.0 |
Humans |
15.8 ± 0.8 |
6.5 ± 0.3 |
no data |
(data from
earlier publications)
2.
Blood formate levels and pH
Methanol
intoxication of pretreated rats resulted in acidosis and blood formate
levels which were comparable to those seen in intoxicated monkeys and
humans. Blood formate concentration ranged between 8-15 mM for 30-40
hours in the treated rats.
Similar
blood formate concentrations over these time periods have been shown to
produce ocular toxicity in monkeys and are associated with visual
toxicity in human methanol intoxication.
Species |
Blood Formate (mM) |
Blood pH |
Rat, N2O-treated |
16.1 ± 0.7 |
6.91 ± 0.06 |
Monkeys |
11.4 ± 1.2 |
7.19 ± 0.02 |
Humans |
19.3 ± 4.4 |
6.93 ± 0.02 |
(rat
data: means ± SD from 6 rats; measurements 60 hours after initial dose.
other data: compiled from earlier publications)
3.
Functional tests
Statistically significant changes were seen in both the retinal
function (by ERG; electroretinogram) and the optical nerve integrity (by
FEP; flash-evoked cortical potential) at 36 hours after the initial dose
until the
end of the experiment at 60 hours after initial dosing.
4.
Histopathology
Retina from the methanol-intoxicated rat showed diffuse edema and
vacuolation at the junction of the inner and outer segments of the
photoreceptor cells, and in the retinal pigmented epithelial cells.
Mitochondrial cristae swelling was seen in the retinal pigmented
epithelium cells and photoreceptors of intoxicated rats. Ultrastructural
changes were much less pronounced in the optical nerve than in the
retina.
1. Blood
formate concentrations
The
procedure produced no acidosis. Blood pHs were maintained between 7.4
and 7.6. After 10 h, all animals accumulated maximum formate in blood
between 10 and 30 mEq/L (460 - 1380 mg/L). The
maximum blood levels that were measured were as follows (Report, Table
1)
|
Blood formate (mg/L) |
Time (h) |
Clinical observations |
|
|
|
|
Pupillary reflex |
Fundus changes (a) |
Animal 1 |
1560 |
39 |
No response Mydriasis 8 mm |
Moderate |
Animal 2 |
1380 |
50 |
No response |
Severe |
Animal 3 |
920 |
41 |
Mydriasis 8 mm |
Severe |
Animal 4 |
550 |
25 |
normal |
Moderate |
(a)
= optic disc edema
2. Ocular
effects
Under these conditions, pupillary reflexes were rapidly altered, and in
most animals no response to light was observed between 24 and 48 h.
Ophthalmology revealed marked optic disc edema (mainly in the prelaminar
region, central portion of the proximal part of the optic nerve without
significantly reaching to the distal part. The retina including the
ganglion-cell layer was completely normal.
Intracellular formate concentrations increased from basal concentrations of 3 +/- 0.5 µmoles formate/mg protein to 38 +/- 4 µmoles formate/mg protein following 2 hours of exposure to either formate or formic acid. However, by 24 h of exposure intracellular formate concentrations were significantly greater in cells exposed to formic acid than in cells exposed to sodium formate. (50 +/- 5 µmoles formate/mg protein vs 17 +/- 2 µmoles formate/mg protein).
Intracellular
ATP concentrations were significantly decreased in cells exposed
to formic acid following 2 hr (70% of control) or 24 hr (50% of control)
of exposure. ATP concentrations were not altered in cells exposed to
sodium formate.
Significant
decreases in cell viability as assessed by propidium iodide
staining were also apparent at 2 h in formic acid exposed cultures, but not
in sodium formate exposed cultures.
Intracellular formate concentrations increased from basal concentrations of 3 +/- 0.5 µmoles formate/mg protein to 38 +/- 4 µmoles formate/mg protein following 2 hours of exposure to either formate or formic acid. However, by 24 h of exposure intracellular formate concentrations were significantly greater in cells exposed to formic acid than in cells exposed to sodium formate. (50 +/- 5 µmoles formate/mg protein vs 17 +/- 2 µmoles formate/mg protein).
Intracellular
ATP concentrations were significantly decreased in cells exposed
to formic acid following 2 hr (70% of control) or 24 hr (50% of control)
of exposure. ATP concentrations were not altered in cells exposed to
sodium formate.
Significant
decreases in cell viability as assessed by propidium iodide
staining were also apparent at 2 h in formic acid exposed cultures, but not
in sodium formate exposed cultures.
RS-Freetext:
Cell growth: formate at 1 - 10 mM stimulated cell growth but
inhibited cell proliferation at 20 mM from day 6 onwards.
The release of LDH did not vary between control and treated
cells.
Growth inhibition increased with dose and chain length
(propionate and butyrate).
Biosynthesis: Formate inhibited the incorporation of
thymidine, uridine, methionine and glucosamine into the
respective macromolecules at all dose levels including 1 mM
after 48-h exposure.
Transepithelial electrical resistance: slightly but
statistically not significantly increased in cells exposed
to 1 or 2 mM formate for 48 h. The resistance to S.
enteritidis was not influenced.
RS-Freetext:
In kidney proximal tubule the addition of 50 µM formate
caused an intracellular alkalization in the absence of
CO2/HCO3. The pH was increased from the baseline level pH of
7.15 to 7.36 (p<0.05). The effect was reversible upon
removal of formate.
Acetate did not alter the pH-value.
Description of key information
Formate is a moderate respiratory chain inhibitor (Ki approx. 6 mM) which may be associated with ocular damage seen when elevated formate levels persist (approx. blod levels 7mM, min. 24 hours). The ocular damage is associated with low hepatic folate levels and, hence, slow formate metabolism. It was demonstrated to occur in vitro, and in vivo in non-human primates (monkeys) and in pretreated rats receiving formate.
Additional information
Experimental animals metabolise formate more rapidly than humans and non-human primates, primarily due to higher hepatic folate levels. As a consequence, formate does not accumulate. It may, however, accumulate in humans and monkeys. Therefore, these species differences obscure potential adverse formate effects in experimental animals but may occur in humans.
After methanol poisoning, irreversible ocular toxicity (retina, optical nerve) is seen in humans but not in rodents, and it is attributable to folate. This was confirmed by experiments in vitro and in vivo where functional and morphological changes of the retina and the optical nerve were demonstrated with formic acid and sodium formate (Emmrich, 2002). Monkeys developed ocular lesions when plasma formate levels were increased over an extended period of time (>550 mg/L [approx. 12 mM], > 24 hours) by means of i.v. infusion of sodium formate (Martin-Amat, 1978). Additionally, a rat model was developed to demonstrate ocular toxicity in rats. Pretreatment with N2O significantly reduces the folate level in rats, and functional and morphological lesions are then obtained in rats receiving methanol or sodium formate (Eells, 2000). Formate-induced retinal toxicity in pretreated, methanol-intoxicated rats was recently demonstrated to occur at 2.6 mM formate after 24 hours (Seme, 1999). According to Hanzlik, blood formate must exceed 7 mM (i.e. 315 mg/L) for at least 24 hours to produce irreversible ocular damage to occur in humans.
Folate is a moderate inhibitor (Ki approx 6 mM) of cytochrome c oxydase, i.e. it impairs respiratory chain and proper ATP supply of the affected cells, it favours generation of lactic acid and, hence, acidosis on a cellular level (Nicholls, 1976; Erecinska and Wilson, 1980). This pattern was seen in photoreceptor cells and optical nerve cells after in vitro or in vivo formate treatment. However, the exact mechanism of ocular toxicity is still not fully understood. It should be noted that folate treatment in vivo does not lead to acidosis, in contrast to methanol poisoning.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.